Unnamed: 0,title,date,stock,sentiment
163630.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,BIO,negative
163631.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,BIO,negative
163632.0,"Altimmune Launches Clinical Trial Of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19 Coronavirus",2020-06-01 07:02:00-04:00,BIO,positive
163633.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,BIO,positive
163634.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,BIO,positive
163635.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-26 10:32:00-04:00,BIO,neutral
163636.0,Stocks That Hit 52-Week Highs On Friday,2020-05-22 10:31:00-04:00,BIO,neutral
163637.0,"Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $525",2020-05-21 07:20:00-04:00,BIO,negative
163638.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,BIO,neutral
163639.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,BIO,positive
163640.0,Biodesix And Bio-Rad Collaborate To Launch Serology Test To Detect Coronavirus (COVID-19) Antibodies,2020-05-19 07:11:00-04:00,BIO,neutral
163641.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,BIO,neutral
163642.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,BIO,neutral
163643.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-12 10:41:00-04:00,BIO,neutral
163644.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,BIO,negative
163645.0,"The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda",2020-05-08 07:59:00-04:00,BIO,neutral
163646.0,"Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $525",2020-05-07 12:39:00-04:00,BIO,neutral
163647.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-07 10:33:00-04:00,BIO,neutral
163648.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,BIO,negative
163649.0,"Bio-Rad Laboratories Q1 EPS $1.910 Beats $1.610 Estimate, Sales $571.600M Beat $554.890M Estimate",2020-05-06 16:48:00-04:00,BIO,neutral
163650.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,BIO,positive
163651.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,BIO,positive
163652.0,"A Peek Into The Markets: US Stock Futures Rise Ahead Of Earnings, Economic Reports",2020-05-05 05:47:00-04:00,BIO,neutral
163653.0,Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit,2020-05-05 05:36:00-04:00,BIO,negative
163654.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,BIO,neutral
163655.0,"The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO",2020-05-01 07:54:00-04:00,BIO,neutral
163656.0,"Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA",2020-04-30 16:51:00-04:00,BIO,negative
163657.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,BIO,positive
163658.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,BIO,positive
163659.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,BIO,neutral
163660.0,Stocks That Hit 52-Week Highs On Monday,2020-04-27 10:21:00-04:00,BIO,neutral
163661.0,Bio-Rad Labs Highlights Began Shipping Coronavirus Antibody Test,2020-04-21 08:31:00-04:00,BIO,neutral
163662.0,"Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $480",2020-04-20 12:51:00-04:00,BIO,neutral
163663.0,Stocks That Hit 52-Week Highs On Friday,2020-04-17 10:19:00-04:00,BIO,neutral
163664.0,"The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement",2020-04-17 07:35:00-04:00,BIO,positive
163665.0,"The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant",2020-04-16 08:09:00-04:00,BIO,neutral
163666.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,BIO,neutral
163667.0,"Bio-Rad Reports Purchase Of Celsee, No Terms Disclosed",2020-04-09 08:34:00-04:00,BIO,negative
163668.0,Bio-Rad Labs Reports Launch Of Serology Assay To Detect Coronavirus Antibodies,2020-04-07 08:35:00-04:00,BIO,neutral
163669.0,"Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Lowers Price Target to $385",2020-03-30 10:36:00-04:00,BIO,negative
163670.0,"Barclays Maintains Overweight on Bio-Rad Laboratories, Lowers Price Target to $430",2020-03-26 10:41:00-04:00,BIO,negative
163671.0,"Citigroup Maintains Buy on Bio-Rad Laboratories, Lowers Price Target to $425",2020-03-20 08:58:00-04:00,BIO,negative
163672.0,Biodesix Reports Partnership With Bio-Rad Labs To Bring Coronavirus Disease Droplet Digital PCR Test To FDA For Emergency Use Authorization Approval,2020-03-20 07:18:00-04:00,BIO,positive
163673.0,Bio-Rad Laboratories Announced that its Real-Time qPCR Products are being Used by Testing Laboratories Globally to Screen for COVID-19,2020-03-19 05:32:00-04:00,BIO,neutral
163674.0,Bio-Rad Announces Launch of SARS CoV-2 Standard for Coronavirus (COVID-19) Testing,2020-03-13 05:24:00-04:00,BIO,neutral
163675.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,BIO,negative
163676.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-20 10:26:00-05:00,BIO,neutral
163677.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,BIO,negative
163678.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-19 10:32:00-05:00,BIO,neutral
163679.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,BIO,negative
163680.0,Stocks That Hit 52-Week Highs On Friday,2020-02-14 10:15:00-05:00,BIO,neutral
163681.0,"Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $440",2020-02-14 08:23:00-05:00,BIO,negative
163682.0,Bio-Rad Sees FY20 Sales Growth 4.5-5.25%,2020-02-13 16:15:00-05:00,BIO,positive
163683.0,"Bio-Rad Laboratories Q4 Adj. EPS $2.32 Misses $2.44 Estimate, Sales $624.4M Miss $641.95M Estimate",2020-02-13 16:15:00-05:00,BIO,negative
163684.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,BIO,negative
163685.0,"Earnings Scheduled For February 13, 2020",2020-02-13 04:27:00-05:00,BIO,neutral
163686.0,Stocks That Hit 52-Week Highs On Friday,2020-01-10 12:18:00-05:00,BIO,neutral
163687.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,BIO,positive
163688.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,BIO,neutral
163689.0,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",2020-01-09 08:39:00-05:00,BIO,positive
163690.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,BIO,positive
163691.0,"Wells Fargo Initiates Coverage On Bio-Rad Laboratories with Overweight Rating, Announces $430 Price Target",2020-01-08 08:51:00-05:00,BIO,negative
163692.0,"The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results",2020-01-08 08:12:00-05:00,BIO,positive
163693.0,"Citigroup Initiates Coverage On Bio-Rad Laboratories with Buy Rating, Announces $450 Price Target",2020-01-07 07:07:00-05:00,BIO,neutral
163694.0,The International Trade Commission Issues Final Decision Affirming 10X Genomics Infringement Of Three Of Bio-Rad's Patents,2019-12-23 08:37:00-05:00,BIO,negative
163695.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,BIO,positive
163696.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,BIO,positive
163697.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,BIO,positive
163698.0,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",2019-12-12 07:38:00-05:00,BIO,positive
163699.0,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",2019-12-05 07:14:00-05:00,BIO,positive
163700.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-04 10:30:00-05:00,BIO,neutral
163701.0,Ra Pharmaceuticals Announces Dosing Of First Patient In Phase 2 Clinical Trial Of Zilucoplan For IMNM,2019-12-04 07:00:00-05:00,BIO,neutral
163702.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-27 10:14:00-05:00,BIO,neutral
163703.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,BIO,negative
163704.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-26 11:03:00-05:00,BIO,neutral
163705.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,BIO,positive
163706.0,Stocks That Hit 52-Week Highs On Monday,2019-11-25 10:19:00-05:00,BIO,neutral
163707.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,BIO,positive
163708.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-20 10:12:00-05:00,BIO,neutral
163709.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,BIO,positive
163710.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,BIO,neutral
163711.0,Stocks That Hit 52-Week Highs On Monday,2019-11-18 11:01:00-05:00,BIO,neutral
163712.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,BIO,negative
163713.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,BIO,neutral
163714.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,BIO,positive
163715.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,BIO,negative
163716.0,"Bio-Rad Laboratories Q3 EPS $1.61 Beats $1.4 Estimate, Sales $560.6M Miss $565.03M Estimate",2019-10-31 16:31:00-04:00,BIO,negative
163717.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,BIO,positive
163718.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,BIO,neutral
163719.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,BIO,neutral
163720.0,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data",2019-10-23 07:54:00-04:00,BIO,negative
163721.0,"The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger",2019-09-24 08:12:00-04:00,BIO,positive
163722.0,Stocks That Hit 52-Week Highs On Monday,2019-09-23 12:51:00-04:00,BIO,neutral
163723.0,"Biome Sees Revenue Quadruple, Gross Profits Triple In Q2",2019-08-29 18:13:00-04:00,BIO,negative
163724.0,Stocks That Hit 52-Week Highs On Wednesday,2019-08-21 10:17:00-04:00,BIO,neutral
163725.0,"The Daily Biotech Pulse: Ra Pharma Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform",2019-08-21 07:40:00-04:00,BIO,neutral
163726.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-20 10:27:00-04:00,BIO,neutral
163727.0,"Benzinga's Top Upgrades, Downgrades For August 20, 2019",2019-08-20 09:33:00-04:00,BIO,positive
163728.0,"Goldman Sachs Upgrades Bio-Rad Laboratories to Conviction Buy, Announces $400 Price Target",2019-08-20 07:17:00-04:00,BIO,neutral
163729.0,"Bio-Rad Laboratories Q2 EPS $1.57 Beats $1.33 Estimate, Sales $572.6M Beat $566.19M Estimate",2019-08-01 16:43:00-04:00,BIO,neutral
163730.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,BIO,negative
163731.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,BIO,negative
163732.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Wed., June 19, 2019",2019-06-19 13:06:00-04:00,BIO,positive
163733.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Tue., June 18, 2019",2019-06-18 13:19:00-04:00,BIO,positive
163734.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Mon., June 17, 2019",2019-06-17 13:43:00-04:00,BIO,positive
163735.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool From Yesterday, Mon., June 10, 2019",2019-06-11 09:16:00-04:00,BIO,positive
163736.0,Bio-Rad Labs shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2019-05-09 10:02:00-04:00,BIO,positive
163737.0,"Deutsche Bank Maintains Buy on Bio-Rad Laboratories, Inc. Class A Common Stock, Raises Price Target to $375",2019-05-09 09:25:00-04:00,BIO,neutral
163738.0,"Barclays Maintains Overweight on Bio-Rad Laboratories, Inc. Class A Common Stock, Raises Price Target to $350",2019-05-09 09:12:00-04:00,BIO,negative
163739.0,"Bio-Rad Laboratories Q1 Adj. EPS $1.65 Beats $1.1 Estimate, Sales $553.979M Beat $549.56M Estimate",2019-05-08 16:56:00-04:00,BIO,neutral
163740.0,Sensus Healthcare Awarded Brachytherapy Products Agreement With Premier,2019-05-08 09:35:00-04:00,BIO,positive
163741.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,BIO,negative
163742.0,"Earnings Scheduled For May 8, 2019",2019-05-08 04:39:00-04:00,BIO,neutral
163743.0,Otonomy Announces OTIPRIO Co-Promotion Agreement With Glenmark Therapeutics For Acute Otitis Externa Indication,2019-05-02 07:58:00-04:00,BIO,positive
163744.0,'New NIO ET Preview Electric Car Revealed In Shanghai' -Inside EVs,2019-04-16 09:58:00-04:00,BIO,neutral
163745.0,Bio-Rad Reports Received FDA Clearance For IH-500,2019-04-08 16:15:00-04:00,BIO,neutral
163746.0,Bio-Rad Labs Reports FDA Clearance For BioPlex 2200 Lyme Total Assay,2019-04-02 08:36:00-04:00,BIO,neutral
163747.0,Bio-Rad Labs Reports Received Expected NYSE Notice Regarding Late Form 10-K Filing,2019-03-25 17:00:00-04:00,BIO,neutral
163748.0,81 Biggest Movers From Friday,2019-03-04 05:39:00-05:00,BIO,neutral
163749.0,64 Stocks Moving In Friday's Mid-Day Session,2019-03-01 13:18:00-05:00,BIO,neutral
163750.0,Bio-Rad Laboratories shares are trading higher after the company beat Q4 EPS estimates; several banks also raised their price target on the company's stock.,2019-03-01 12:10:00-05:00,BIO,positive
163751.0,"Deutsche Bank Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $350",2019-03-01 10:21:00-05:00,BIO,neutral
163752.0,"Barclays Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $340",2019-03-01 10:12:00-05:00,BIO,negative
163753.0,"The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis",2019-03-01 08:50:00-05:00,BIO,neutral
163754.0,"Bio-Rad Laboratories Q4 Adj. EPS $2.13 Beats $1.50 Estimate, Sales $617.5M Down From $620.433M YoY",2019-02-28 16:43:00-05:00,BIO,neutral
163755.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,BIO,positive
163756.0,"Earnings Scheduled For February 28, 2019",2019-02-28 04:08:00-05:00,BIO,neutral
163757.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,BIO,neutral
163758.0,Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response,2019-02-15 04:40:00-05:00,BIO,neutral
163759.0,"Veru Announces Scientific Presentations For Novel Prostate Cancer Drug Candidates 
At 2019 American Society Of Clinical Oncology Genitourinary Cancers Symposium",2019-02-12 08:05:00-05:00,BIO,negative
163760.0,"Barclays Upgrades Bio-Rad Laboratories to Overweight, Announces $315",2019-01-03 07:05:00-05:00,BIO,negative
163761.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,BIO,neutral
163762.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,BIO,neutral
163763.0,UPDATE: Bio-Rad To Receive $23.9M In Damages,2018-11-14 08:33:00-05:00,BIO,negative
163764.0,"Bio-Rad, University Of Chicago Report Winning Of Patent Infringement Case Against 10X Genomics Related To Droplet Microfluidics Technologies",2018-11-14 08:32:00-05:00,BIO,positive
163765.0,Bio-Rad Wins USDA Contract For Its Pathogen Detection Testing Products; Financial Terms Not Disclosed,2018-11-13 08:45:00-05:00,BIO,positive
163766.0,"Barclays Maintains Equal-Weight on Bio-Rad Laboratories, Lowers Price Target to $315",2018-11-02 12:33:00-04:00,BIO,negative
163767.0,"Bio-Rad Laboratories, Inc. Q3 Adj. EPS $0.91 Misses $1.18 Estimate, Sales $545.1M Beat $539.78M Estimate",2018-11-01 16:33:00-04:00,BIO,negative
163768.0,Bio-Rad Gets FDA Clearance For IH-Reader 24,2018-10-29 08:30:00-04:00,BIO,neutral
163769.0,"Benzinga's Top Upgrades, Downgrades For October 17, 2018",2018-10-17 09:09:00-04:00,BIO,positive
163770.0,"Goldman Sachs Initiates Coverage On Bio-Rad Laboratories with Buy Rating, Announces $350 Price Target",2018-10-17 05:54:00-04:00,BIO,neutral
163771.0,10 Biggest Price Target Changes For Monday,2018-09-24 10:04:00-04:00,BIO,neutral
163772.0,"Jefferies Adds Bio-Rad Labs To Its 'Franchise Picks' List; Maintains Buy Rating, Raises Price Target From $355 To $420",2018-09-24 07:39:00-04:00,BIO,neutral
163773.0,"Benzinga's Top Upgrades, Downgrades For September 20, 2018",2018-09-20 09:13:00-04:00,BIO,positive
163774.0,"Morgan Stanley Initiates Coverage On Bio-Rad Laboratories with Equal-Weight Rating, Announces $335 Price Target",2018-09-20 07:40:00-04:00,BIO,neutral
163775.0,"Benzinga's Top Upgrades, Downgrades For September 5, 2018",2018-09-05 09:10:00-04:00,BIO,positive
163776.0,"Barclays Initiates Coverage On Bio-Rad Laboratories with Equal-Weight Rating, Announces $345 Price Target",2018-09-05 07:08:00-04:00,BIO,neutral
163777.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,BIO,neutral
163778.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,BIO,neutral
163779.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,BIO,positive
163780.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,BIO,neutral
163781.0,10 Biggest Price Target Changes For Wednesday,2018-08-08 09:44:00-04:00,BIO,neutral
163782.0,"Jefferies Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $355",2018-08-08 08:17:00-04:00,BIO,neutral
163783.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,BIO,positive
163784.0,Bio-Rad Laboratories Raises FY18 Sales Growth Outlook From 3.5-4% to 4-4.5%,2018-08-07 17:56:00-04:00,BIO,positive
163785.0,"Bio-Rad Laboratories Q2 Adj. EPS $1.64 Beats $1.27 Estimate, Sales $575.911M Beat $548.43M Estimate",2018-08-07 17:55:00-04:00,BIO,neutral
163786.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,BIO,neutral
163787.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,BIO,negative
163788.0,"Earnings Scheduled For August 7, 2018",2018-08-07 04:49:00-04:00,BIO,neutral
163789.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,BIO,neutral
163790.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,BIO,positive
163791.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,BIO,neutral
163792.0,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",2018-07-27 08:44:00-04:00,BIO,neutral
163793.0,"Stocks Which Set New 52-Week High Yesterday, July 25th",2018-07-26 11:00:00-04:00,BIO,neutral
163794.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,BIO,negative
163795.0,"Stocks Which Set New 52-Week High Yesterday, July 24th:",2018-07-25 12:14:00-04:00,BIO,neutral
163796.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,BIO,positive
163797.0,"Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering",2018-07-24 08:53:00-04:00,BIO,positive
163798.0,Stocks Which Set New 52-Week High Yesterday,2018-07-20 09:05:00-04:00,BIO,neutral
163799.0,"Benzinga's Daily Biotech Pulse: PTC To Buy Agilis, Zynerba To Offer Shares, Intuitive Surgical's Strong Q2",2018-07-20 07:53:00-04:00,BIO,positive
163800.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,BIO,neutral
163801.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,BIO,negative
163802.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,BIO,positive
163803.0,"Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs",2018-06-08 09:20:00-04:00,BIO,positive
163804.0,"Benzinga's Daily Biotech Pulse: Insmed Presents Data, Pfenex Pulls Back On Offering, Oncolytics Listing",2018-05-23 08:15:00-04:00,BIO,neutral
163805.0,"Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict",2018-05-22 08:05:00-04:00,BIO,positive
163806.0,"Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More",2018-05-17 08:27:00-04:00,BIO,neutral
163807.0,"Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway",2018-05-15 08:44:00-04:00,BIO,positive
163808.0,"Bio-Rad Shares Halted On Circuit Breaker On Very Light Volume, ~4K Shares; Stock Up 1.9%",2018-05-11 09:46:00-04:00,BIO,positive
163809.0,"Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again",2018-05-11 08:21:00-04:00,BIO,negative
163810.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,BIO,neutral
163811.0,"BZ NOTE On Move Higher In Bio-Rad: Price Action, In Addition To Q1 Earnings, Could Be Related To Recent Trader Interest In Low-Float Stocks; Co. Has ~30M Shares Outstanding",2018-05-09 09:54:00-04:00,BIO,positive
163812.0,"Bio-Rad Labs Shares Halted On Circuit Breaker, Up 9.4%; Co. Late Tues. Reported Better-Than-Expected Q1 Results",2018-05-09 09:53:00-04:00,BIO,positive
163813.0,Bio-Rad Sees FY18 Sales Growth 3.5-4%,2018-05-08 16:26:00-04:00,BIO,positive
163814.0,"Bio-Rad Laboratories Q1 EPS $1.17 Beats $1.09 Estimate, Sales $551.5M Beat $527.77M Estimate",2018-05-08 16:26:00-04:00,BIO,neutral
163815.0,Bio-Rad Labs Reports Received Expected NYSE Notice Related To Late Form 10-K Filing,2018-03-22 07:09:00-04:00,BIO,neutral
163816.0,Bio-Rad Says it Cannot File its FY17 10K On Time Due to Financial Data Issues,2018-03-16 06:24:00-04:00,BIO,neutral
163817.0,"BioScrip Sees FY18 EPS $(0.41)-$(0.34) vs $(0.21) Est., Sales $710-$720M vs $716M Est.",2018-03-08 08:07:00-05:00,BIO,neutral
163818.0,"Wells Fargo Maintains Outperform on Bio-Rad Laboratories, Lowers Price Target to $280.00",2018-02-28 09:51:00-05:00,BIO,positive
163819.0,"Bio-Rad Shares Halted On Low-Volume Circuit Breaker, Up 6.5% For Session",2018-02-28 09:46:00-05:00,BIO,positive
163820.0,"Bio-Rad Reports Q4 GAAP EPS $2.32 vs $(0.70) In Same Qtr. Last Year, Sales $620.4M vs $619.2M Est.",2018-02-27 16:28:00-05:00,BIO,neutral
163821.0,"Benzinga's Top Upgrades, Downgrades For February 16, 2018",2018-02-16 09:21:00-05:00,BIO,positive
163822.0,CL King Downgrades Bio-Rad Laboratories to Neutral,2018-02-16 07:42:00-05:00,BIO,neutral
163823.0,Bio-Rad Labs Reports Gained Added FDA Clearances For Blood-Typing Products,2018-01-22 16:22:00-05:00,BIO,positive
163824.0,Bio-Rad Authorizes New $250M Share Buyback,2017-11-28 09:01:00-05:00,BIO,positive
163825.0,55 Biggest Movers From Friday,2017-11-06 05:58:00-05:00,BIO,neutral
163826.0,48 Stocks Moving In Friday's Mid-Day Session,2017-11-03 12:30:00-04:00,BIO,neutral
163827.0,Bio-Rad Laboratories Shares Up 15.8%; Thursday Co. Reported Strong Q3 Results But Guided Q4 Below Consensus Estimates,2017-11-03 10:27:00-04:00,BIO,positive
163828.0,Bio-Rad Sees Q4 Sales $615-$625M vs $707M Est.,2017-11-02 16:59:00-04:00,BIO,neutral
163829.0,"Bio-Rad Reports Q3 EPS $0.91 vs $0.62 In Prior Year Period, Sales 535M vs $508M Est.",2017-11-02 16:59:00-04:00,BIO,neutral
163830.0,US ITC to Investigate Complaint by Bio-Rad Labs Related to Microfluidic Devices from 10X Genomics -Reuters,2017-08-31 08:18:00-04:00,BIO,negative
163831.0,"Bio-Rad Reports Q2 EPS $0.17 vs $0.61 In Same Qtr. Last Year, Sales $504.7M vs $515.78M Est.",2017-08-03 17:18:00-04:00,BIO,neutral
163832.0,"Wells Fargo Initiates Coverage On Bio-Rad Laboratories with Outperform Rating, Announces $250.00 Price Target",2017-07-13 06:27:00-04:00,BIO,positive
163833.0,"With 'Tunnel's End' In Sight, Deutsche Upgrades Bio-Rad Labs",2017-06-28 12:22:00-04:00,BIO,neutral
163834.0,"Benzinga's Top Upgrades, Downgrades For June 28, 2017",2017-06-28 09:26:00-04:00,BIO,positive
163835.0,Deutsche Bank Upgrades Bio-Rad Laboratories to Buy,2017-06-28 07:02:00-04:00,BIO,neutral
163837.0,"Bio-Rad Reports FDA Clearance Of BioPlex 2200 Syphilis Total, RPR Assay",2017-06-12 08:37:00-04:00,BIO,neutral
163839.0,"Bio-Rad Reports Q1 EPS $0.41 vs $0.30 Est., Sales $500M vs $477M Est.",2017-05-04 17:22:00-04:00,BIO,neutral
163840.0,"Corvex's Keith Meister Talks Strategy, Recent Success In Bio-Rad",2017-04-27 13:58:00-04:00,BIO,positive
163841.0,BioRad Labs Spikes to High of $219.34 on Volume,2017-04-27 11:26:00-04:00,BIO,neutral
163842.0,"Bio-Rad Sees Long-Term Sales Growth Of ~3-5%, Currency-Neutral EBITDA Margin Of Greater Than 20% By 2020",2017-03-13 08:33:00-04:00,BIO,positive
163843.0,"Bio-Rad Reports Q4 EPS $(0.70) vs. YoY $1.68, Decrease In Net Income Due To Several Non-Cash Charges Including $59.9M In Goodwill And IPR&D Impairment",2017-02-23 16:28:00-05:00,BIO,negative
163844.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,BIO,positive
163845.0,"Deutsche Bank Initiates Coverage On Bio-Rad Laboratories At Hold, Announces $195 Price Target",2017-01-18 08:08:00-05:00,BIO,neutral
163846.0,Bio-Rad Laboratories to Acquire RainDance Technologies; Terms Not Disclosed,2017-01-16 17:09:00-05:00,BIO,neutral
163847.0,8-K from Bio Rad Labs Shows California Superior Court Issued Order Granting Prelim. Approval for Proposed Settlement,2016-12-27 14:57:00-05:00,BIO,positive
163848.0,"Bio-Rad Reports Q3 EPS $0.62 vs $0.51 Est., Sales $508.7M vs $480.6M Est.",2016-11-01 16:59:00-04:00,BIO,neutral
163849.0,Bio-Rad Reports IH-1000 Blood Typing Instrument Receives Clearance For FDA,2016-10-24 08:33:00-04:00,BIO,neutral
163850.0,Bio-Rad Laboratories Investor Forum Wraps Up Today,2016-10-19 08:27:00-04:00,BIO,neutral
163851.0,Bio-Rad Laboratories Begins Its Investor Forum Today,2016-10-18 08:38:00-04:00,BIO,neutral
163852.0,Globavir Announces Licensing Agreement with Bio-Rad for Globavir's Dengue Detection Technology; Terms Not Disclosed,2016-10-17 05:01:00-04:00,BIO,positive
163853.0,"CL King Earlier Initiated Coverage On Bio-Rad Laboratories, Inc. Class A Common Stock at Buy",2016-10-13 11:35:00-04:00,BIO,neutral
163854.0,"Bio-Rad Reports Q2 Adj EPS $1.48, Rev $516.8M vs $497.8M Est",2016-08-03 18:01:00-04:00,BIO,neutral
163855.0,"Bio-Rad Reports Q1 EPS $0.42 vs. Est. $0.60, Rev. $471.2M vs. Est. $497M",2016-05-05 16:45:00-04:00,BIO,neutral
163856.0,"Bio-Rad Reports Q4 EPS $1.68 vs $1.27 Est., Sales $570.6M vs $570.8M Est.",2016-02-25 17:20:00-05:00,BIO,neutral
163857.0,"Bio-Rad, Illumina To Co-Develop Comprehensive Solution For Single-Cell Genomics, Companies Expect To Launch Solution In Late 2016 or Early 2017",2016-01-11 14:32:00-05:00,BIO,positive
163858.0,Bio-Rad Reports TANGO infinity Has Received FDA 510(k) Clearance for US Markets,2015-12-21 16:21:00-05:00,BIO,neutral
163859.0,"Bio-Rad Laboratories Q3 EPS $0.59 Vs Est $0.54, Sales $470M Vs Est $495.55M",2015-11-03 16:28:00-05:00,BIO,neutral
163860.0,"Bio-Rad Laboratories Reports Q2 EPS $0.97 Vs Est $0.78, Sales $506.01M Vs Est $494.85M",2015-08-06 17:47:00-04:00,BIO,neutral
163861.0,"Bio-Rad Reports Q2 EPS $0.97 vs. Est. $0.78, Rev. $506.1M vs. Est. $494.85M",2015-08-06 17:07:00-04:00,BIO,neutral
163862.0,"Bio-Rad Reports U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab Assay, a Novel Next Generation HIV Diagnostic Test",2015-07-28 16:16:00-04:00,BIO,positive
163863.0,FDA Approves BioRad Diagnostic Test to Differentiate Between Types of HIV Infection,2015-07-23 15:02:00-04:00,BIO,positive
163864.0,Bio-Rad Reports FDA Clearance for VARIANT II TURBO HbA1c Kit 2.0,2015-06-09 16:29:00-04:00,BIO,neutral
163865.0,"Bio-Rad Labs Earlier Reported Q1 EPS $0.61, Sales $472.8M vs $474.6M Est.",2015-05-05 17:50:00-04:00,BIO,neutral
163866.0,"Bio-Rad Announces Granting of Beckman Coulter Exclusive Distribution Rights for Access HIV, Hep C Assays",2015-04-20 08:36:00-04:00,BIO,positive
163867.0,"Bio-Rad Reports Q4 EPS $1.34, Rev. $598.2M",2015-02-26 16:17:00-05:00,BIO,neutral
163868.0,"IMF to Provide $150M Support for Liberia, Sierra Leone, Guinea, Due to Ebola Epidemic -Reuters",2015-01-08 14:20:00-05:00,BIO,positive
163869.0,"UPDATE: WHO Says Sierra Leone Cases Leveling Off, But Still Worst Country Affected",2015-01-07 14:37:00-05:00,BIO,negative
163870.0,"WHO Reports Ebola Death Toll Rises to 8,235 from 20,747 Cases Worldwide Through January 4",2015-01-07 14:36:00-05:00,BIO,negative
163871.0,"CDC Removes Mali from List of Ebola Affected Countries; Guinea, Liberia, Sierra Leone Remain at Warning Level 3 -Reuters",2015-01-05 13:24:00-05:00,BIO,negative
163872.0,"WHO Reports 7,905 Ebola Deaths from 20,206 Cases at Year End",2014-12-31 13:16:00-05:00,BIO,neutral
163873.0,UPDATE: Ebola Patient Moved from Scotland to London; Second Patient Being Tested in Scotland -NY Times,2014-12-30 06:27:00-05:00,BIO,neutral
163874.0,"WHO Reports Ebola Death Toll Approaching 8,000 from 20,000+ Cases",2014-12-29 11:34:00-05:00,BIO,negative
163875.0,Bio-Rad Receives Premarket Application Approval For Its Geenius HIV 1/2 Supplemental Assay,2014-11-18 16:18:00-05:00,BIO,positive
163876.0,5 Health Care Stocks Hurting From The Affordable Care Act,2014-11-04 20:46:00-05:00,BIO,positive
163877.0,"Bio-Rad Laboratories, Inc. Reports Q3 EPS of $0.39; Revenue of $530.60M vs $525.39M Est",2014-11-04 16:29:00-05:00,BIO,neutral
163878.0,UPDATE: Bio-Rad Labs Announces Resolution of Foreign Corrupt Practices Act,2014-11-03 14:21:00-05:00,BIO,neutral
163879.0,Bio-Rad Labs Announces Resolution of Foreign Corrupt Practices Act ,2014-11-03 14:20:00-05:00,BIO,neutral
163880.0,Bio-Rad Laboratories to Pay $14.35M Penalty to Resolve Foreign Corrupt Practices Act Investigation; $40.7M to Resolve SEC Case -Reuters,2014-11-03 12:46:00-05:00,BIO,positive
163881.0,Bio-Rad Appoints John Goetz As COO,2014-10-01 16:17:00-04:00,BIO,neutral
163882.0,"Bio-Rad Laboratories, Inc. Reports Q2 EPS of $1.09 vs $0.95 Est",2014-08-05 16:19:00-04:00,BIO,neutral
163883.0,Bio-Rad Announces The Appointment Of New Board Member ,2014-07-25 16:15:00-04:00,BIO,neutral
163884.0,"Bio-Rad Buys GnuBIO, No Terms Disclosed",2014-04-11 08:42:00-04:00,BIO,negative
163885.0,"Bio-Rad Laboratories, Inc. Reports Q4 EPS of $1.04 vs $1.42 Est; Revenue of $602.60M, Up 5% YOY",2014-02-27 16:23:00-05:00,BIO,neutral
163886.0,"Bio-Rad Laboratories, Inc. Reports Q3 EPS of $(0.25) Which May Not Compare $0.91 Est; Revenue of $505.10M Which May Not Compare $529.02M Est",2013-11-07 17:27:00-05:00,BIO,neutral
163887.0,"Bio-Rad Laboratories, Inc. Reports Q2 EPS of $1.20 vs $1.25 Est; Revenue of $525.30M vs $532.60M Est",2013-08-06 16:38:00-04:00,BIO,neutral
163888.0,"Bio-Rad Laboratories, Inc. Reports Q1 EPS of $0.68 vs $1.06 Est; Revenue of $499.70M vs $506.34M Est",2013-05-07 16:56:00-04:00,BIO,neutral
163889.0,"UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Bio-Rad Laboratories on 4Q12 Non-GAAP EPS",2013-02-27 11:52:00-05:00,BIO,neutral
163890.0,"Jefferies Maintains Buy on Bio-Rad Laboratories, Inc., Raises PT to $140.00",2013-02-27 07:25:00-05:00,BIO,neutral
163891.0,"Bio-Rad Laboratories, Inc. Reports Q4 EPS of $1.65 Which May Not Compare $1.34 Est; Revenue of $573.80M",2013-02-26 16:18:00-05:00,BIO,neutral
163892.0,"CLSA Upgrades Bio-Rad Laboratories, Inc. to Outperform, Raises PT to $124.00",2013-01-17 07:54:00-05:00,BIO,neutral
163893.0,Bio-Rad Labs Buys AbD Serotec for €53M,2013-01-10 09:07:00-05:00,BIO,neutral
163894.0,Bio-Rad Laboratories Reports Q3 EPS $1.48 vs $1.17 Est; Revenues $498.7M vs $506.14M Est,2012-11-06 16:30:00-05:00,BIO,neutral
163895.0,Bio-Rad Acquires Cell Sorting System From Propel Labs,2012-10-31 08:39:00-04:00,BIO,neutral
163896.0,Bio-Rad and Myriad RBM Partner to Commercialize Multiplex Biomarker Kits for Life Science Research ,2012-07-24 16:18:00-04:00,BIO,neutral
163897.0,5 Scientific & Technical Instruments Stocks With The Highest Revenue,2012-07-03 07:49:00-04:00,BIO,neutral
163898.0,Top 4 Mid-Cap Stocks In The Scientific & Technical Instruments Industry With The Highest Cash,2012-06-18 02:42:00-04:00,BIO,positive
163899.0,"Benzinga's Top Downgrades With Color for May 2, 2012",2012-05-02 12:23:00-04:00,BIO,positive
163900.0,UPDATE: Dougherty & Company Downgrades Bio-Rad Laboratories,2012-05-02 10:04:00-04:00,BIO,neutral
163901.0,"Dougherty & Company Downgrades Bio-Rad Laboratories from Buy to Neutral, Maintains PT at $108",2012-05-02 08:29:00-04:00,BIO,neutral
163902.0,UPDATE: Jefferies Increases PT to $125 on Bio-Rad Laboratories; Improved Profitability  ,2012-05-02 08:05:00-04:00,BIO,positive
163903.0,"Jefferies & Company Maintains Bio-Rad Laboratories at Buy, Raises PT from $120 to $125",2012-05-02 07:04:00-04:00,BIO,neutral
163904.0,Bio-Rad Laboratories Reports Q1 EPS $1.09 vs $1.11 Est; Revenues $486.3M vs $492.35M Est,2012-05-01 16:29:00-04:00,BIO,neutral
163905.0,Vermillion Resolves Non-Contingent Claims with Bio-Rad; Vermillion to be Returned More Than $1M from Escrow  ,2012-04-30 08:32:00-04:00,BIO,positive
163906.0,"AFFX, BIO Moving Higher on Mad Cow Disease Rumors; TSN, WEN, MCD Moving Lower",2012-04-24 14:44:00-04:00,BIO,negative
163907.0,Bio-Rad Laboratories up 12.7% After Announcing Agreement with Luminex ,2012-04-03 10:39:00-04:00,BIO,positive
163908.0,"Jefferies & Company Maintains Bio-Rad Laboratories at Buy, Lowers PT from $130 to $120",2012-02-24 09:39:00-05:00,BIO,negative
163909.0,Bio-Rad Laboratories Reports Q4 Prelim EPS $2.08 vs $1.67 Est; Revenues $550.2M vs $562.06M Est	 			,2012-02-23 16:32:00-05:00,BIO,neutral
163910.0,Hearing CLSA Downgrades Bio Rad Labs,2012-01-31 11:00:00-05:00,BIO,neutral
163911.0,Hearing BioRad Labs Downgraded at CLSA,2012-01-31 11:00:00-05:00,BIO,neutral
163912.0,Top 4 Mid-Cap Stocks In The Scientific & Technical Instruments Industry With The Highest Cash,2011-12-08 04:20:00-05:00,BIO,positive
163913.0,Bio-Rad Downgraded to Outperform at CLSA,2011-11-30 08:08:00-05:00,BIO,neutral
163914.0,Bio-Rad Labs Guides 2011 Organic Revenue Growth 3.5-4%; Down from 5% the Company Had Previously Expected,2011-11-01 17:22:00-04:00,BIO,positive
163915.0,Bio-Rad Labs Guides 2011 Operating Margin 13-15%; Gross Margin 56-56.5%; Capex in the Range of $100M,2011-11-01 17:15:00-04:00,BIO,negative
163916.0,Bio-Rad Labatories Reports Q3 EPS $1.61 vs $1.53 Est; Revenues $516.5M vs $511.47M Est		,2011-11-01 16:20:00-04:00,BIO,neutral
163917.0,"Earnings Preview: Becton, Dickinson & Company's EPS, Revenue Expected to Rise",2011-10-28 12:51:00-04:00,BIO,neutral
163918.0,"Thermo Fisher Scientific Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-24 12:25:00-04:00,BIO,neutral
163919.0,"General Electric Company Earnings Preview: Analysts Expect Falling Revenue, Rising EPS",2011-10-18 16:12:00-04:00,BIO,negative
163920.0,UPDATE: Jefferies Lowers PT on Bio-Rad Laboratories to $135,2011-10-06 07:22:00-04:00,BIO,negative
163921.0,Jefferies Lowers PT on Bio-Rad Laboratories to $135,2011-10-06 06:15:00-04:00,BIO,negative
163922.0,Bio-Rad Acquires QuantaLife and Digital PCR Technology  for $162M in Cash,2011-10-05 08:30:00-04:00,BIO,neutral
163923.0,"Eating Healthier, Part 1: Understanding Genetically Modified Foods and Their Dangers",2011-09-27 01:32:00-04:00,BIO,negative
163924.0,Jefferies Comments On Bio-Rad Laboratories 2Q11 EPS,2011-08-03 08:19:00-04:00,BIO,neutral
163925.0,Bio-Rad Labs Reports Q2 EPS $1.41 vs $1.47 Est; Revenues $521.7M vs $508.17M Est  	   ,2011-08-02 16:17:00-04:00,BIO,neutral
163926.0,"Earnings Preview: Becton, Dickinson and Company EPS, Revenue Expected to Rise from Previous Quarter",2011-07-28 12:34:00-04:00,BIO,neutral
163927.0,Bio-Rad Receives FDA Premarket Application Approval for Its Fourth-Generation HIV Assay  ,2011-07-25 08:32:00-04:00,BIO,positive
163928.0,"Thermo Fisher Scientific Earnings Preview: Analyts Expect Higher Earnings, Revenue from Prior Quarter",2011-07-22 13:11:00-04:00,BIO,neutral
163929.0,"General Electric Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-19 12:08:00-04:00,BIO,neutral
163930.0,"General Electric Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-19 11:06:00-04:00,BIO,neutral
163931.0,"Top 4 Mid-Cap Stocks In The Scientific & Technical Instruments Industry With The Highest Cash (GRMN, WAT, BIO, BEC)",2011-05-05 00:31:00-04:00,BIO,positive
163932.0,UPDATE: Jefferies Color On BIO Target Increase,2011-05-04 09:20:00-04:00,BIO,positive
163933.0,Jefferies Raises PT On Bio-Rad Laboratories To $145,2011-05-04 07:39:00-04:00,BIO,neutral
163934.0,Bio-Rad Labs Reports EPS of $1.16 vs. $1.32 Estimate; Revenues $485.1M vs. $482.11M Estimate,2011-05-03 16:21:00-04:00,BIO,neutral
163935.0,"Top Percentage Gainers And Losers As Of 2 p.m. 4/12/2011 (CYH, THC, IDIX, BAC, SKH, JPM, BIO, REDF, DEER, THC, CYTX, CCRT, WMS, EXTR, LFT, SB, DRRX, BRNC, MCRL)",2011-04-12 14:09:00-04:00,BIO,negative
163936.0,Zacks #1 Rank Additions for Wednesday - Tale of the Tape,2010-12-15 08:33:00-05:00,BIO,neutral
163937.0,Zacks #1 Rank Additions for Wednesday - Tale of the Tape,2010-12-15 08:14:00-05:00,BIO,neutral
163938.0,Leerink Swann & Co Upgrades BIO To Outperform,2010-12-08 08:09:00-05:00,BIO,neutral
163939.0,Bio-Rad To Refinance Debt,2010-12-07 09:23:00-05:00,BIO,negative
163940.0,Zacks #1 Rank Additions for Friday  - Tale of the Tape,2010-11-05 09:33:00-04:00,BIO,neutral
163941.0,Decent Booth Traffic for Immucor and Bio-Rad at This Year's AABB,2010-10-11 09:26:00-04:00,BIO,neutral
163942.0,"Top 4 NYSE Stocks In The Technology Industry With The Highest EPS Estimates (CEL, IBM, WDC, BIO)",2010-07-13 05:52:00-04:00,BIO,positive
163943.0,"Top 5 Mid-Cap Stocks In The Technology Sector With The Highest EPS Estimates (CEL, PTNR, DNB, CSC, BIO)",2010-01-20 07:00:00-05:00,BIO,positive
163944.0,Bio-Rad Laboratories Inc. (BIO) Downgraded To Equal-Weight,2010-01-19 09:30:00-05:00,BIO,neutral
163945.0,Bio-Rad Laboratories Inc. (BIO) Denies Patent Infringement ,2009-12-24 10:52:00-05:00,BIO,negative
163946.0,Somaxon Pharmaceuticals (SOMX)  to Present at 8th Annual BIO Investor Forum ,2009-10-22 09:13:00-04:00,BIO,neutral
